Jaguar Health Inc. (JAGX)
JAGX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.16
-10.35% on the day
Market cap
$32.5M
Nano cap
Revenue · 2025
$11.5M
-1.5% on 2024
Net income · 2025
-$54K
-0.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | JAGX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001585608 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $11.5M |
| Net income | -$54K |
| Operating income | -$45.9M |
| Net margin | -0.5% |
| Operating margin | -398.8% |
| Revenue growth | -1.5% |
| Cash | $968K |
| Total assets | $38.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-24 |
| Latest annual report | 10-K | 2026-04-07 |
| Latest quarterly / interim | 10-Q | 2026-08-19 |
| Latest current report | 8-K | 2026-10-05 |
| Latest proxy | DEF 14A | 2026-10-08 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $0.9995 | -5.71% | $31.4M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier